Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,002 public trials 569 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592

Conditions
B-cell Malignancy, Low-grade, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute at St. Elizabeth's Brighton, Massachusetts, United States
  • Dana Farber Cancer Institute at Merrimack Valley Methuen, Massachusetts, United States
  • Dana Farber Cancer Institute at Milford Regional Medical Center Milford, Massachusetts, United States
View Trial Details
Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

NCT06022939

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 117 locations
View Trial Details
Recruiting

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

NCT04771572

Conditions
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +48 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

NCT05099471

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Onkologische Schwerpunktpraxis Bielefeld Bielefeld, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
  • Klinikverbund Allgaeu gGmbH Kempten, Germany
  • Universitaetsklinikum Schleswig-Holstein AöR Kiel, Germany
View all 14 locations
View Trial Details
Recruiting

Methods of T Cell Depletion Trial (MoTD)

NCT04888741

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations
  • University Hospital of Wales Cardiff, Wales, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
View all 17 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT05020236

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Clovis Community Medical Center Clovis, California, United States
  • Community Regional Medical Center Fresno, California, United States
  • UCHealth Poudre Valley Hospital Fort Collins, Colorado, United States
  • UCHealth Greeley Hospital Greeley, Colorado, United States
View all 90 locations
View Trial Details

Related conditions